Travere Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TVTX Nasdaq 2830 travere.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Travere Therapeutics, Inc.

Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027 - Jun 16th, 2026 2:30 pm
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now? - Jun 13th, 2026 2:45 pm
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 11th, 2026 3:00 pm
3 Stocks That May Be Priced Below Their Estimated Value In June 2026 - Jun 8th, 2026 11:38 am
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress - Jun 4th, 2026 8:09 am
Extreme Networks And 2 Other Stocks That Could Be Trading Below Their Estimated Value - Jun 3rd, 2026 11:38 am
3 Stocks That May Be Priced Below Their Estimated Worth In June 2026 - Jun 3rd, 2026 5:38 am
TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside - Jun 2nd, 2026 12:14 pm
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases - Jun 2nd, 2026 6:27 am
Travere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases - Jun 2nd, 2026 5:01 am
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy - May 27th, 2026 2:05 pm
Discover 3 Stocks That May Be Trading Below Their Estimated Value - May 27th, 2026 11:38 am
Dow Jones Leader Amazon, AI Stock Quanta, Monster Beverage In Or Near Buy Zones - May 26th, 2026 11:25 am
3 Stocks That May Be Undervalued By The Market In May 2026 - May 21st, 2026 11:38 am
Fifth Third Bancorp And 2 Stocks Possibly Undervalued For Consideration - May 21st, 2026 5:39 am
3 Stocks Estimated To Be Trading Below Intrinsic Value By 11.4% To 38.4% - May 20th, 2026 11:38 am
Agilysys And Two Other Stocks Priced Below Estimated Value - May 20th, 2026 5:38 am
Discover 3 Stocks Including CoStar Group Estimated Below Intrinsic Value - May 19th, 2026 11:38 am
3 Stocks That May Be Priced Below Their Estimated Value In May 2026 - May 18th, 2026 11:38 am
Three Companies Priced Below Estimated Value In May 2026 - May 18th, 2026 5:37 am